Prof Chng Wee Joo
Prof Chng Wee Joo
NUS Vice President (Biomedical Sciences Research),
weejoo.chng@nus.edu.sg
Professor Chng Wee Joo is Vice President (Biomedical Sciences Research) at the National University of Singapore. In this role, he spearheads the development of the University’s biomedical-related research, as well as strategic collaborations with academic institutes, hospitals and industrial partners. Presently the Yong Loo Lin Professor in Medical Oncology, Professor Chng is also a Senior Principal Investigator at the Cancer Science Institute of Singapore and concurrently serves as the Group Director of Research at the National University Health System and the inaugural Executive Director of the Singapore Translational Cancer Consortium.
A hematologist by training, Professor Chng is an esteemed researcher in the fields of genomics, therapeutics and hematologic malignancies, with a wealth of experience spanning clinical practice, administration, and leadership. He has produced highly translational research, including using global genomic techniques to understand drug resistance and improve disease prognosis in hematological malignancies — that has helped to personalise treatment and improve patient outcomes. His impactful research has won him numerous national and global accolades, including the International Myeloma Foundation’s Brian G.M. Durie Outstanding Achievement Award in 2020 — becoming the first in Asia to achieve this honour — and the National Medical Research Council’s National Outstanding Clinician Scientist Award in 2016.
Professor Chng has been a Senior Consultant at the National University Cancer Institute, Singapore for over two decades, and was Vice Dean of Research at the Yong Loo Lin School of Medicine (2022 – 2023), Director of the National University Cancer Institute, Singapore (2014– 2023), and Provost’s Chair (2018 – 2022). He is also a member of numerous leading national and international professional committees, including the American Association of Cancer Research, the International Myeloma Working Group and the Asian Myeloma Network, and was former President of the Singapore Society of Hematology.
Professor Chng obtained his medical degree from the University of Leeds, and completed his internal medicine residency and fellowship training in hematology in the United Kingdom and Singapore respectively.